Harel Insurance Investments & Financial Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.83M | Buy |
1,528
+450
| +42% | +$460K | 0.01% | 175 |
|
|
2026
Q1 | $989K | Buy |
1,078
+454
| +73% | +$460K | 0.01% | 168 |
|
|
2025
Q4 | $667K | Sell |
624
-513
| -45% | -$491K | 0.01% | 190 |
|
|
2025
Q3 | $864K | Buy |
1,137
+364
| +47% | +$271K | 0.01% | 198 |
|
|
2025
Q2 | $603K | Buy |
773
+262
| +51% | +$204K | 0.01% | 202 |
|
|
2025
Q1 | $422K | Buy |
511
+186
| +57% | +$155K | 0.01% | 218 |
|
|
2024
Q4 | $251K | Sell |
325
-81
| -20% | -$67.1K | ﹤0.01% | 197 |
|
|
2024
Q3 | $360K | Buy |
406
+131
| +48% | +$118K | 0.01% | 185 |
|
|
2024
Q2 | $249K | Sell |
275
-257
| -48% | -$206K | ﹤0.01% | 240 |
|
|
2024
Q1 | $414K | Buy |
+532
| New | +$379K | 0.01% | 184 |
|
|
2023
Q4 | – | Sell |
-603
| Closed | -$324K | – | 654 |
|
|
2023
Q3 | $324K | Buy |
+603
| New | +$311K | 0.01% | 233 |
|
|
2023
Q2 | – | Sell |
-1,345
| Closed | -$460K | – | 752 |
|
|
2023
Q1 | $460K | Buy |
1,345
+1,040
| +341% | +$351K | 0.01% | 241 |
|
|
2022
Q4 | $112K | Sell |
305
-1,897
| -86% | -$673K | ﹤0.01% | 345 |
|
|
2022
Q3 | $727K | Buy |
2,202
+1,802
| +451% | +$571K | 0.02% | 181 |
|
|
2022
Q2 | $130K | Sell |
400
-6,600
| -94% | -$1.98M | ﹤0.01% | 377 |
|
|
2022
Q1 | $2M | Sell |
7,000
-6,000
| -46% | -$1.54M | 0.03% | 154 |
|
|
2021
Q4 | $3.6M | Sell |
13,000
-463
| -3% | -$117K | 0.07% | 100 |
|
|
2021
Q3 | $3.11M | Buy |
13,463
+11,329
| +531% | +$2.8M | 0.08% | 82 |
|
|
2021
Q2 | $1.6M | Sell |
2,134
-503
| -19% | -$101K | 0.04% | 240 |
|
|
2021
Q1 | $1.65M | Sell |
2,637
-9,363
| -78% | -$1.83M | 0.03% | 277 |
|
|
2020
Q4 | $6.52M | Buy |
12,000
+41
| +0.3% | +$6.12K | 0.15% | 71 |
|
|
2020
Q3 | $1.77M | Buy |
11,959
+11,596
| +3,194% | +$1.79M | 0.06% | 83 |
|
|
2020
Q2 | $60K | Buy |
363
+120
| +49% | +$18.4K | ﹤0.01% | 387 |
|
|
2020
Q1 | $34K | Buy |
+243
| New | +$33.4K | ﹤0.01% | 295 |
|
|
2019
Q4 | – | Sell |
-550
| Closed | -$62K | – | 520 |
|
|
2019
Q3 | $62K | Sell |
550
-1,209
| -69% | -$135K | ﹤0.01% | 288 |
|
|
2019
Q2 | $195K | Buy |
1,759
+800
| +83% | +$94.2K | 0.01% | 195 |
|
|
2019
Q1 | $124K | Sell |
959
-1,151
| -55% | -$140K | 0.01% | 169 |
|
|
2018
Q4 | $244K | Hold |
2,110
| – | – | 0.02% | 161 |
|
|
2018
Q3 | $226K | Hold |
2,110
| – | – | 0.01% | 194 |
|
|
2018
Q2 | $180K | Hold |
2,110
| – | – | 0.01% | 193 |
|
|
2018
Q1 | $163K | Hold |
2,110
| – | – | 0.01% | 229 |
|
|
2017
Q4 | $178K | Buy |
2,110
+300
| +17% | +$25.5K | 0.01% | 222 |
|
|
2017
Q3 | $155K | Hold |
1,810
| – | – | 0.01% | 205 |
|
|
2017
Q2 | $149K | Sell |
1,810
-4,561
| -72% | -$372K | 0.01% | 212 |
|
|
2017
Q1 | $525K | Buy |
+6,371
| New | +$510K | 0.05% | 84 |
|
|
2016
Q3 | – | Sell |
-1,805
| Closed | -$142K | – | 593 |
|
|
2016
Q2 | $142K | Buy |
+1,805
| New | +$136K | 0.02% | 201 |
|
Other funds holding LLY
Harel Insurance Investments & Financial Services's LLY Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services increased its Eli Lilly (LLY) stake by 42% in Q2 2026, buying an estimated $460K and bringing the position to 1,528 shares worth $1.83M. The position accounts for 0.01% of the portfolio, ranked #175.
Harel Insurance Investments & Financial Services first reported a position in LLY in Q2 2016 and has held it in 36 quarters since. The position peaked at $6.52M in Q4 2020. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Harel Insurance Investments & Financial Services held 1,528 shares of Eli Lilly worth $1.83M as of Q2 2026.
- Harel Insurance Investments & Financial Services bought 450 Eli Lilly shares in Q2 2026, an estimated $460K.
- Eli Lilly made up 0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #175 holding.
- Harel Insurance Investments & Financial Services first reported a position in Eli Lilly in Q2 2016 and has held it in 36 quarters since.
- Harel Insurance Investments & Financial Services's Eli Lilly position peaked at $6.52M in Q4 2020.
- 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.